The most important thing is to start! Success in EU represents half the global market and would smooth the regulatory path for the US in round two. I'm happy they are taking this lower risk approach, rather than trying to cram two competing objectives into the one trial.
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.914M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5434 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 99600 | 1 |
View Market Depth
| Last trade - 16.11pm 07/08/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable